Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKUS

Akouos (AKUS) Stock Price, News & Analysis

Akouos logo

About Akouos Stock (NASDAQ:AKUS)

Advanced Chart

Key Stats

Today's Range
$13.29
$13.29
50-Day Range
$13.29
$13.29
52-Week Range
$2.32
$13.60
Volume
440 shs
Average Volume
344,411 shs
Market Capitalization
$490.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AKUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akouos and its competitors with MarketBeat's FREE daily newsletter.

AKUS Stock News Headlines

NOVARTIS AG's Net Worth
Joshua Makower's Net Worth
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
William W. Backus Hospital
See More Headlines

AKUS Stock Analysis - Frequently Asked Questions

Akouos, Inc. (NASDAQ:AKUS) issued its earnings results on Friday, November, 12th. The company reported ($0.67) EPS for the quarter, missing analysts' consensus estimates of ($0.63) by $0.04.

Akouos (AKUS) raised $124 million in an IPO on Friday, June 26th 2020. The company issued 8,300,000 shares at $14.00-$16.00 per share. BofA Securities, Cowen and Piper Sandler served as the underwriters for the IPO and BTIG was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akouos investors own include Advanced Micro Devices (AMD), Atreca (BCEL), Editas Medicine (EDIT), Homology Medicines (FIXX), Avidity Biosciences (RNA), Alector (ALEC) and Gossamer Bio (GOSS).

Company Calendar

Last Earnings
11/12/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:AKUS
CIK
1722271
Fax
N/A
Employees
103
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.62)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$86.67 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-45.09%
Return on Assets
-36.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
17.30
Quick Ratio
17.30

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.90 per share
Price / Book
2.71

Miscellaneous

Outstanding Shares
36,936,000
Free Float
35,163,000
Market Cap
$490.88 million
Optionable
Not Optionable
Beta
-0.55
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:AKUS) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners